“Hot Topics in Migraine,” Presented by the Association of Migraine Disorders
“Hot Topics in Migraine,” will be a series of short presentations on new migraine research and treatments, followed by a panel discussion. The event is free and open to the public and will be presented by the Association of Migraine Disorders. Robert Shapiro, M.D., well-known researcher from Vermont, will speak about securing funding for migraine research. Brian McGeeney, M.D. of Massachusetts, will discuss the use of marijuana for the treatment of migraine. Professor Lyn Griffiths, of Australia, will talk about her research on genetic testing for migraine. Richard Boles, M.D. and Medical Director of Courtogen, will discuss his clinical research in genetic testing and migraine as well as Next Generation Sequencing and how it can provide custom reports to assist doctors in making the most informative treatment recommendations. Lastly, Anne St Goar, M.D., of Massachusetts, will speak about Methylenedioxymethamphetamine (MDMA) for PTSD.
The event is free and open to the public, however, seating is limited. To reserve your free ticket for
this event, please call 401-855-6249 or email email@example.com.
The Association of Migraine Disorders is a 501(c)(3) nonprofit organization with a mission to end the suffering from migraine illness through research, education and collaboration. The organization was founded by otolaryngologists who saw migraine at the root of many head and neck medical conditions. AMD has developed a comprehensive research program that offers research grants for new and experienced researchers, including funding the nation’s first post-doctoral fellowship in migraine research at the Brown Institute for Brain Science. The organization is committed to developing unique, high-quality informational materials, videos and clinical tools to help a broad range of medical professionals learn how to recognize and treat migraine disorders. AMD is also dedicated to providing information and support for migraine sufferers, and to raising the public consciousness about the impact of this devastating disease.